How to Get Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania: Complete Appeals Guide with Forms and Timelines
Answer Box: Getting Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania
Fastest path to approval: Submit prior authorization through CVS Caremark or Aetna provider portal with IDH1 mutation test results, AML diagnosis confirmation, and documented failure of preferred alternatives. If denied, request peer-to-peer review within 180 days, then file